We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
-4.62%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$74.4B
AUM Growth
+$4.15B
Cap. Flow
+$8.44B
Cap. Flow %
11.35%
Top 10 Hldgs %
19.16%
Holding
4,480
New
238
Increased
1,135
Reduced
2,408
Closed
335

Sector Composition

Rank Sector Weight
1 Technology 12.15%
2 Consumer Discretionary 6.92%
3 Financials 5.66%
4 Healthcare 5.15%
5 Industrials 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJS icon
3876
iShares S&P Small-Cap 600 Value ETF
IJS
$8.36B
$307 ﹤0.01%
3
-552
-99% -$56.3K
IHT
3877
InnSuites Hospitality Trust
IHT
$15.5M
$305 ﹤0.01%
+100
New +$320
CDTX
3878
DELISTED
Cidara Therapeutics
CDTX
$294 ﹤0.01%
18
-9
-33% -$153
AAIC
3879
DELISTED
Arlington Asset Investment Corp.
AAIC
$285 ﹤0.01%
82
HURC icon
3880
Hurco Companies Inc
HURC
$144M
$284 ﹤0.01%
9
-67
-88% -$2.18K
UXIN
3881
Uxin Ltd
UXIN
$249M
$283 ﹤0.01%
3
-183
-98% -$20.9K
XFOR icon
3882
X4 Pharmaceuticals
XFOR
$425M
$280 ﹤0.01%
5
-4
-44% -$229
ELOX
3883
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$274 ﹤0.01%
12
-4
-25% -$79
ALOT icon
3884
AstroNova
ALOT
$227M
$273 ﹤0.01%
18
BSMX
3885
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$262 ﹤0.01%
50
ARL icon
3886
American Realty Investors
ARL
$243M
$261 ﹤0.01%
17
-111
-87% -$1.53K
IJT icon
3887
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.42B
$250 ﹤0.01%
+2
New +$252
AFI
3888
DELISTED
Armstrong Flooring, Inc.
AFI
$250 ﹤0.01%
175
GYRE icon
3889
Gyre Therapeutics
GYRE
$706M
$243 ﹤0.01%
49
-13
-21% -$64
VTVT icon
3890
vTv Therapeutics
VTVT
$125M
$238 ﹤0.01%
8
-12
-60% -$359
PHUN icon
3891
Phunware
PHUN
$43M
$208 ﹤0.01%
2
OVID icon
3892
Ovid Therapeutics
OVID
$489M
$198 ﹤0.01%
63
IDN icon
3893
Intellicheck
IDN
$74.7M
$191 ﹤0.01%
75
RVLP
3894
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$181 ﹤0.01%
+107
New +$153
LOGC
3895
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$171 ﹤0.01%
252
-185
-42% -$203
GNPX icon
3896
Genprex
GNPX
$2.39M
0
OVBC icon
3897
Ohio Valley Banc Corp
OVBC
$211M
$150 ﹤0.01%
5
TWIN icon
3898
Twin Disc
TWIN
$355M
$150 ﹤0.01%
9
ASMB icon
3899
Assembly Biosciences
ASMB
$536M
$144 ﹤0.01%
6
-71
-92% -$1.52K
MRKR icon
3900
Marker Therapeutics
MRKR
$19.3M
$135 ﹤0.01%
31
+7
+29% +$40

Similar funds

BNP Paribas Financial Markets's Q1 2022 Portfolio in Review

As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.

  • BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
  • BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
  • BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
  • BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
  • BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
  • BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
  • BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.